The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review

References

• Abbott, D. H., D. K. Barnett, C. M. Bruns, and D. A. Dumesic. 2005. Androgen excess fetal programming of female reproduction: A developmental aetiology for polycystic ovary syndrome? Human Reproduction Update 11:357–74. doi:10.1093/humupd/dmi013.
   PubMed Web of Science ®Google Scholar
• Álvarez-Blasco, F., J. I. Botella-Carretero, J. L. San Millán, and H. F. Escobar-Morreale. 2006. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Archives of Internal Medicine 166:2081–86. doi:10.1001/archinte.166.19.2081.
   PubMedGoogle Scholar
• Andrade, M. N., A. P. Santos-Silva, P. Rodrigues-Pereira, F. D. Paiva-Melo, N. C. De Lima Junior, M. P. Teixeira, P. Soares, G. R. M. Dias, J. B. Graceli, D. P. De Carvalho, A. C. F. Ferreira, and L. Miranda-Alves. 2018. The environmental contaminant tributyltin leads to abnormalities in different levels of the hypothalamus-pituitary-thyroid axis in female rats. Environmental Pollution 241:636–45. doi:10.1016/j.envpol.2018.06.006.
   PubMed Web of Science ®Google Scholar
• Antizar-Ladislao, B. 2008. Environmental levels, toxicity and human exposure to tributyltin (TBT)-contaminated marine environment. A review. Environment International 34:292–308. doi:10.1016/j.envint.2007.09.005.
   PubMed Web of Science ®Google Scholar
• Attina, T. M., R. Hauser, S. Sathyanarayana, P. A. Hunt, J. P. Bourguignon, J. P. Myers, J. DiGangi, R. T. Zoeller, and L. Trasande. 2016. Exposure to endocrine-disrupting chemicals in the USA: A population-based disease burden and cost analysis. Lancet Diabetes Endocrinology 4:996–1003. doi:10.1016/S2213-8587(16)30275-3.
   PubMed Web of Science ®Google Scholar
• Azenha, M., and M. T. Vasconcelos. 2002. Butyltin compounds in Portuguese wines. Journal of Agricultural and Food Chemistry 50:2713–16.
   PubMed Web of Science ®Google Scholar
• Azziz, R., E. Carmina, Z. Chen, A. Duanif, J. S. Laven, R. S. Legro, D. Lizneva, B. Natterson-Horowtiz, H. J. Teede, and B. O. Yildiz. 2016. Polycystic ovary syndrome. Nature Reviews Disease Primers 2:16057. doi:10.1038/nrdp.2016.57.
   PubMed Web of Science ®Google Scholar
• Azziz, R., C. Marin, L. Hog, E. Badamgaray, and P. Song. 2005. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. Journal of Clinical Endocrinology & Metabolism 90:4650–58. doi:10.1210/jc.2005-0628.
   PubMed Web of Science ®Google Scholar
• Bahceci, M., M. Aydemir, and A. Tuzcu. 2007. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome. Fertility and Sterility 87:1363–68. doi:10.1016/j.fertnstert.2006.11.031.
   PubMed Web of Science ®Google Scholar
• Baillargeon, J. P., and J. E. Nestler. 2006. Polycystic ovary syndrome: A syndrome of ovarian hypersensitivity to insulin? Journal of Clinical Endocrinology and Metabolism 91:22–24. doi:10.1210/jc.2005-1804.
   PubMed Web of Science ®Google Scholar
• Balen, A. 2004. The pathophysiology of polycystic ovary syndrome: Trying to understand PCOS and its endocrinology. Best Practice and Research Clinical Obstetrics and Gynaecology 18:685–706. doi:10.1016/j.bpobgyn.2004.05.004.
   PubMed Web of Science ®Google Scholar
• Baptiste, C. G., M.-C. Battista, A. Trottier, and J.-P. Baillargeon. 2010. Insulin and hyperandrogenism in women with polycystic ovary syndrome. Journal of Steroid Biochemistry and Molecular Biology 122:42–52. doi:10.1016/j.jsbmb.2009.12.010.
   PubMed Web of Science ®Google Scholar
• Bassaganya-Riera, J., S. Misyak, A. J. Guri, and R. Hontecillas. 2009. PPAR γ is highly expressed in F4/80hi adipose tissue macrophages and dampens adipose-tissue inflammation. Cellular Immunology 258:138–46. doi:10.1016/j.cellimm.2009.04.003.
   PubMed Web of Science ®Google Scholar
• Beloosesky, R., R. Gold, B. Almog, R. Sasson, A. Dantes, A. Land-Bracha, L. Hirsh, J. Itskovitz-Eldor, J. B. Lessing, R. Homburg, and A. Amsterdam. 2004. Induction of polycystic ovary by testosterone in immature female rats: Modulation of apoptosis and attenuation of glucose/insulin ratio. International Journal of Molecular Medicine 14:207–15. http://www.ncbi.nlm.nih.gov/pubmed/15254767.
   PubMed Web of Science ®Google Scholar
• Benrick, A., B. Chanclón, P. Micallef, Y. Wu, L. Hadi, J. M. Shelton, E. Stener-Victorin, and I. Wernstedt Asterholm. 2017. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model. Proceedings of the National Academy of Sciences of the United States of America 114:E7187–E196. doi:10.1073/pnas.1708854114.
   PubMed Web of Science ®Google Scholar
• Bertuloso, B. D., P. L. Podratz, E. Merlo, J. F. De Araújo, L. C. F. Lima, E. C. De Miguel., L. N. De Souza, A. L. Gava, M. De Oliveria, L. Miranda-Alves, M. T. Carneiro, C. R. Nogueira, and J. B. Graceli. 2015. Tributyltin chloride leads to adiposity and impairs metabolic functions in the rat liver and pancreas. Toxicology Letters 235:45–59. doi:10.1016/j.toxlet.2015.03.009.
   PubMed Web of Science ®Google Scholar
• Bo, E., A. Farinetti, M. Marraudino, D. Sterchele, C. Eva, S. Gotti, and G. Panzica. 2016. Adult exposure to tributyltin affects hypothalamic neuropeptide Y, Y1 receptor distribution, and circulating leptin in mice. Andrology 4:723–734. doi.org/10.1111/andr.12222.
   PubMed Web of Science ®Google Scholar
• Bosselmann, K. 1996. Environmental law and tributyltin in the environment. In Tributyltin, edited by. S. J. De Mora, 237–63. Cambridge: Cambridge University Press. doi:10.1017/CBO9780511759772.009.
   Google Scholar
• Boumosleh, J. M., S. M. Grundy, J. Phan, I. J. Neeland, A. Chang, and G. L. Vega. 2017. Metabolic concomitants of obese and nonobese women with features of polycystic ovarian syndrome. Journal of the Endocrine Society 1:1417–27. doi:10.1210/js.2017-00323.
   Web of Science ®Google Scholar
• Brothers, K. J., S. Wu, S. A. DiVall, M. R. Messmer, C. R. Kahn, R. S. Miller, S. Radovick, F. E. Wondisford, and A. Wolfe. 2010. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metabolism 12:295–305. doi:10.1016/j.cmet.2010.06.010.
   PubMed Web of Science ®Google Scholar
• Brown, J. E. P., A. C. Conner, J. E. Digby, K. L. Ward, M. Ramanjaneya, H. S. Randeva, and S. J. Dunmore. 2010. Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin. Peptides 31:944–49. doi:10.1016/j.peptides.2010.02.004.
   PubMed Web of Science ®Google Scholar
• Cai, X., C. Liu, and S. Mou. 2014. Association between fat mass- and obesity-associated (FTO) gene polymorphism and polycystic ovary syndrome: A meta-analysis. PLoS ONE 9:e86972. doi:10.1371/journal.pone.0086972.
   PubMedGoogle Scholar
• Calderon-Margalit, R., D. Siscovick, S. S. Merkin, E. Wang, M. L. Daviglus, P. J. Schreiner, B. Sternfeld, O. Dale Williams, C. E. Lewis, R. Azziz, S. M. Schwartz, and M. F. Wellons. 2014. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness the coronary artery risk development in young adults women’s study. Arteriosclerosis, Thrombosis, and Vascular Biology 34:2688–94. doi:10.1161/ATVBAHA.114.304136.
   PubMed Web of Science ®Google Scholar
• Caldwell, A. S. L., L. J. Middleton, M. Jimenez, R. Desai, A. C. McMahon, C. M. Allan, D. J. Handelsman, and K. A. Walters. 2014. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155:3146–59. doi:10.1210/en.2014-1196.
   PubMed Web of Science ®Google Scholar
• Cao, D., G. Jiang, Q. Zhou, and R. Yang. 2009. Organotin pollution in China: An overview of the current state and potential health risk. Journal of Environmental Management 90:16–24. doi:10.1016/j.jenvman.2008.06.007.
   Web of Science ®Google Scholar
• Cardwell, R. D., J. C. Keithly, and J. Simmonds. 1999. Tributyltin in US market-bought seafood and assessment of human health risks. Human and Ecological Risk Assessment 5:317–35. doi:10.1080/10807039991289464.
   Web of Science ®Google Scholar
• Carfi’, M., C. Croera, D. Ferrario, V. Campi, G. Bowe, R. Pieters, and L. Gribaldo. 2008. TBTC induces adipocyte differentiation in human bone marrow long term culture. Toxicology 249:11–18. doi:10.1016/j.tox.2008.03.025.
   PubMed Web of Science ®Google Scholar
• Carlsen, H., F. Haugen, S. Zadelaar, R. Kleemann, T. Kooistra, C. A. Drevon, and R. Blomhoff. 2009. Diet-induced obesity increases NF-κB signaling in reporter mice. Genes and Nutrition 4:215–22. doi:10.1007/s12263-009-0133-6.
   PubMed Web of Science ®Google Scholar
• Chamorro-García, R., M. Sahu, R. J. Abbey, J. Laude, N. Pham, and B. Blumberg. 2013. Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environmental Health Perspectives 121:359–66. doi:10.1289/ehp.1205701.
   PubMed Web of Science ®Google Scholar
• Chen, X., X. Jia, J. Qiao, Y. Guan, and J. Kang. 2013. Adipokines in reproductive function: A link between obesity and polycystic ovary syndrome. Journal of Molecular Endocrinology 50:R21–R37. doi:10.1530/JME-12-0247.
   PubMed Web of Science ®Google Scholar
• Chien, L. C., T. C. Hung, K. Y. Choang, C. Y. Yeh, P. J. Meng, M. J. Shieh, and B. C. Han. 2002. Daily intake of TBT, Cu, Zn, Cd and As for fishermen in Taiwan. Science of the Total Environment 285:177–85. doi:10.1016/S0048-9697(01)00916-0.
   PubMed Web of Science ®Google Scholar
• Christian, R. C., D. A. Dumesic, T. Behrenbeck, A. L. Oberg, P. F. Sheedy, and L. A. Fitzpatrick. 2003. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88:2562–68. doi:10.1210/jc.2003-030334.
   PubMed Web of Science ®Google Scholar
• Coenen, T. M. M., A. Brower, I. C. Enninga, and J. H. Koeman. 1992. Subchronic toxicity and reproduction effects of tri-n-butyltin oxide in Japanese quail. Archives of Environmental Contamination and Toxicology 23:457–63.
   PubMed Web of Science ®Google Scholar
• Conway, G. S., R. Agrawal, D. J. Betteridge, and H. S. Jacobs. 1992. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clinical Endocrinology 37:119–25. http://www.ncbi.nlm.nih.gov/pubmed/1395062.
   PubMed Web of Science ®Google Scholar
• Cooke, G.M., D.S. Forsyth, G.S. Bondy, R. Tachon, B. Tague, and L. Coady. 2008. Organotin speciation and tissue distribution in rat dams, fetuses, and neonates following oral administration of tributyltin chloride. Journal of Toxicology and Environmental Health, Part A: Current Issues 71:384–395. doi.org/10.1080/15287390701801653.
   PubMed Web of Science ®Google Scholar
• Cooke, G. M., H. Tryphonas, O. Pulido, D. Caldwel, G. S. Bondy, and D. Forsyth. 2004. Oral (gavage), in utero and postnatal exposure of Sprague-Dawley rats to low doses of tributyltin chloride. Part 1: Toxicology, histopathology and clinical chemistry. Food and Chemical Toxicology 42:211–20. doi:10.1016/j.fct.2003.09.003.
   PubMed Web of Science ®Google Scholar
• Coutinho, J. V. S., L. C. Freitas-Lima, F. F. C. T. Freitas, F. P. S. Freitas, P. L. Podratz, R. P. L. Magnago, M. L. Porto, S. S. Meyrelles, E. C. Vasquez, P. A. A. Brandão, M. T. Carneiro, F. D. Paiva-Melo, L. Miranda-Alves, I. V. Silva, A. L. Gava, and J. B. Graceli. 2016. Tributyltin chloride induces renal dysfunction by inflammation and oxidative stress in female rats. Toxicology Letters 260:52–69. doi:10.1016/j.toxlet.2016.08.007.
   PubMed Web of Science ®Google Scholar
• Crowther, N. J., N. Cameron, J. Trusler, and I. P. Gray. 1998. Association between poor glucose tolerance and rapid post natal weight gain in seven-year-old children. Diabetologia 41:1163–67. doi:10.1007/s001250051046.
   PubMed Web of Science ®Google Scholar
• Cussons, A. J., G. F. Watts, V. Burke, J. E. Shaw, P. Z. Zimmet, and B. G. A. Stuckey. 2008. Cardiometabolic risk in polycystic ovary syndrome: A comparison of different approaches to defining the metabolic syndrome. Human Reproduction 23:2352–58. doi:10.1093/humrep/den263.
   PubMed Web of Science ®Google Scholar
• Dalmasso, C., R. Maranon, C. Patil, E. Bui, M. Moulana, H. Zhang, A. Smith, L. L. Yanes Cardozo, and J. F. Reckelhoff. 2016. Cardiometabolic effects of chronic hyperandrogenemia in a new model of postmenopausal polycystic ovary syndrome. Endocrinology 157:2920–27. doi:10.1210/en.2015-1617.
   PubMed Web of Science ®Google Scholar
• De Araújo, J. F. P., P. L. Podratz, G. C. Sena, E. Merlo, L. C. Freitas-Lima, J. G. M. Ayub, A. F. Z. Pereira, A. P. Santos-Silva, L. Miranda-Alves, I. V. Silva, and J. B. Graceli. 2018. The obesogen tributyltin induces abnormal ovarian adipogenesis in adult female rats. Toxicology Letters 295:99–114. doi:10.1016/j.toxlet.2018.06.1068.
   PubMed Web of Science ®Google Scholar
• Decherf, S., and B. A. Demeneix. 2011. The obesogen hypothesis: A shift of focus from the periphery to the hypothalamus. Journal of Toxicology and Environmental Health B 14:423–48. doi:10.1080/10937404.2011.578561.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis, E., K. Alexandraki, A. Protogerou, C. Piperi, C. Papamichael, A. Aessopos, J. Lekakis, and M. Mavrikakis. 2005. Metformin administration improves endothelial function in women with polycystic ovary syndrome. European Journal of Endocrinology 152:749–56. doi:10.1530/eje.1.01910.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis, E., J.-P. Bourguignon, L. C. Giudice, R. Hauser, G. S. Prins, A. M. Soto, R. T. Zoeller, and A. C. Gore. 2009. Endocrine-disrupting chemicals: An endocrine society scientific statement. Endocrine Reviews 30:293–342. doi:10.1210/er.2009-0002.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis, E., C. Christakou, and H. Kandarakis. 2007. Polycystic ovarian syndrome: The commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Minerva Endocrinologica 32:35–47. http://www.ncbi.nlm.nih.gov/pubmed/17353865.
   PubMedGoogle Scholar
• Diamanti-Kandarakis, E., I. Katsikis, C. Piperi, E. Kandaraki, A. Piouka, A. G. Papavassiliou, and D. Panidis. 2008. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clinical Endocrinology 69:634–541. doi:10.1111/j.1365-2265.2008.03247.x.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis, E., C. R. Kouli, A. T. Bergiele, F. A. Filandra, T. C. Tsianateli, G. G. Spina, E. D. Zapanti, and M. I. Bartzis. 1999. A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: Hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 84:4006–11. doi:10.1210/jcem.84.11.6148.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis, E., G. Spina, C. Kouli, and I. Migdalis. 2001. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. Journal of Clinical Endocrinology and Metabolism 86:4666–73. doi:10.1210/jcem.86.10.7904.
   PubMed Web of Science ®Google Scholar
• Dietz, W. H. 1994. Critical periods in childhood for the development of obesity. American Journal of Clinical Nutrition 59:955–59. doi:10.1093/ajcn/59.5.955.
   PubMed Web of Science ®Google Scholar
• Dorneles, P. R., M. A. Fernandez, L. G. Vidal, L. A. Barbosa, A. F. Azevedo, A. B. Fragoso, J. P. Torres, and O. Malm. 2008. Evaluation of cetacean exposure to organotin compounds in Brazilian waters through hepatic total tin concentrations. Environmental Pollution 156:1268–76. doi:10.1016/j.envpol.2008.03.007.
   PubMed Web of Science ®Google Scholar
• Dos Santos, R. L., P. L. Podratz, G. C. Sena, V. S. D. Filho, P. F. I. Lopes, W. L. S. Gonçalves, L. M. Alves, V. Y. Samoto, C. M. Takiya, E. De Castro Miguel, M. R. Moysés, and J. B. Graceli. 2012. Tributyltin impairs the coronary vasodilation induced by 17β-estradiol in isolated rat heart. Journal of Toxicology and Environmental Health A 75:948–59. doi:10.1080/15287394.2012.695231.
   PubMed Web of Science ®Google Scholar
• Dumesic, D. A., S. E. Oberfield, E. Stener-Victorin, J. C. Marshall, J. S. Laven, and R. S. Legro. 2015. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocrine Reviews 36:487–525. doi:10.1210/er.2015-1018.
   PubMed Web of Science ®Google Scholar
• Dunaif, A. 1997. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis 1. Endocrine Reviews 18:774–800. doi:10.1210/edrv.18.6.0318.
   PubMed Web of Science ®Google Scholar
• Dunaif, A., J. Mandeli, H. Fluhr, and A. Dobrjansky. 1988. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 66:131–39. doi:10.1210/jcem-66-1-131.
   PubMed Web of Science ®Google Scholar
• Edwards, D. A. 1971. Neonatal administration of androstenedione, testosterone or testosterone propionate: Effects on ovulation, sexual receptivity and aggressive behavior in female mice. Physiology and Behavior 6:223–28. http://www.ncbi.nlm.nih.gov/pubmed/5166472.
   PubMed Web of Science ®Google Scholar
• Ehrmann, D. A. 2005. Polycystic ovary syndrome. New England Journal of Medicine 352:1223–36. doi:10.1056/NEJMra041536.
   PubMed Web of Science ®Google Scholar
• Elias, C. F. 2012. Leptin action in pubertal development: Recent advances and unanswered questions. Trends in Endocrinology and Metabolism 23:9–15. doi:10.1016/j.tem.2011.09.002.
   PubMed Web of Science ®Google Scholar
• Ema, M., R. Kurosaka, H. Amano, and Y. Ogawa. 1995. Further evaluation of the developmental toxicity of tributyltin chloride in rats. Toxicology 96:195–201.
   PubMed Web of Science ®Google Scholar
• Eriksson, J. G., T. Forsen, J. Tuomilehto, P. D. Winter, C. Osmond, and D. J. P. Barker. 1999. Catch-up growth in childhood and death from coronary heart disease: Longitudinal study. British Medical Journal 318:427–31. doi:10.1136/bmj.318.7181.427.
   PubMed Web of Science ®Google Scholar
• Essah, P. A., and J. E. Nestler. 2006. The metabolic syndrome in polycystic ovary syndrome. Journal of Endocrinological Investigation 29:270–80. doi:10.1007/BF03345554.
   PubMed Web of Science ®Google Scholar
• European Chemicals Agency. 2008. Agreement of the member state committee on identification of bis(tributyltin) oxide (TBTO) as a substance of very high concern. Regulation (EC) No 1907/2006. ECHA/ Europe.
   Google Scholar
• European Food Safety Authority. 2004. Scientific panel on contaminants in the food chain. Opinion on the health risks assessment to consumers associated with the exposure to organotins in foodstuff. Accessed June 21, 2018. https://www.efsa.europa.eu/en/science/contam/contam_opinions/658.html
   Google Scholar
• European Union - Report on Tasks for Scientific Cooperation. 2003. Assessment of the dietary exposure to organotin compounds of the population of the EU Member States, Report on tasks for scientific cooperation. Directorate General Health and Consumer Protection. Accessed June 21, 2018. http://ec.europa.eu/food/food/chemicalsafety/contaminants/scoop_3–2–13_final_report_organotins_en.pdf
   Google Scholar
• Evans, R. M., G. D. Barish, and Y.-X. Wang. 2004. PPARs and the complex journey to obesity. Nature Medicine 10:355–61. doi:10.1038/nm1025.
   PubMed Web of Science ®Google Scholar
• Ewnens, K. G., M. R. Jones, W. Ankener, D. R. Stewart, M. Urbanek, A. Dunaif, R. S. Legro, A. Chua, R. Azziz, R. S. Spielman, M. O. Goodarzi, and J. F. Strauss 3rd. 2011. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One 6:e16390. doi:10.1371/journal.pone.0016390.
   PubMed Web of Science ®Google Scholar
• Fajas, L., D. Auboeuf, E. Raspé, K. Schoonjans, A. M. Lefebvre, R. Saladin, J. Najib, M. Laville, J. C. Fruchart, S. Deeb, A. Vidal-Puig, J. Flier, M. R. Briggs, B. Staels, H. Vidal, and J. Auwerx. 1997. The organization, promoter analysis, and expression of the human PPARgamma gene. Journal of Biological Chemistry 272:18779–89. http://www.ncbi.nlm.nih.gov/pubmed/9228052.
   PubMed Web of Science ®Google Scholar
• Fantuzzi, G. 2005. Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology 115:911–19. doi:10.1016/j.jaci.2005.02.023.
   PubMed Web of Science ®Google Scholar
• Fauser, B. C. J. M. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81:19–25. doi:10.1016/j.fertnstert.2003.10.004.
   Web of Science ®Google Scholar
• FDA USA - United States Food and Drug Administration, 2010. Endocrine Disruptor Knowledge Base. Accessed June 21, 2018. https://www.fda.gov/ScienceResearch/BioinformaticsTools/EndocrineDisruptorKnowledgebase/default.htm
   Google Scholar
• Fent, K. 1996. Ecotoxicology of organotin compounds. Critical Reviews in Toxicology 26:1–117. http://www.ncbi.nlm.nih.gov/pubmed/8833456.
   PubMed Web of Science ®Google Scholar
• Fernandez, M. A., A. M. Limaverde, A. L. Scolfiels, and A. L. R. Wagener. 2005. Preliminary evaluation of human health risks from ingestion of organotin contaminated seafood in Brazil. Brazilian Journal of Oceanography 53:75–77. doi:10.1590/S1679-87592005000100008.
   Google Scholar
• Folsom, A. R., R. A. Kronmal, R. C. Detrano, D. H. O’Leary, D. E. Bild, D. A. Bluemke, M. J. Budoff, K. Liu, S. Shea, M. Szklo, R. P. Tracy, K. E. Watson, and G. L. Burke. 2008. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: The Multi-Ethnic Study of Atherosclerosis (MESA). Archives of Internal Medicine 168:1333–39. doi:10.1001/archinte.168.12.1333.
   PubMed Web of Science ®Google Scholar
• Franks, S. 1995. Polycystic ovary syndrome. New England Journal of Medicine 333:853–61. doi:10.1056/NEJM199509283331307.
   PubMed Web of Science ®Google Scholar
• Franks, S., J. Stark, and K. Hardy. 2008. Follicle dynamics and anovulation in polycystic ovary syndrome. Human Reproduction Update 14:367–78. doi:10.1093/humupd/dmn015.
   PubMed Web of Science ®Google Scholar
• Frederich, R. C., A. Hamann, S. Anderson, B. Löllmann, B. B. Lowell, and J. S. Flier. 1995. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Medicine 1:1311–14. http://www.ncbi.nlm.nih.gov/pubmed/7489415.
   PubMed Web of Science ®Google Scholar
• Frigolet, M. E., N. Torres, and A. R. Tovar. 2013. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. Journal of Nutritional Biochemistry 24:2003–15. doi:10.1016/j.jnutbio.2013.07.002.
   PubMed Web of Science ®Google Scholar
• Funk, J. A., J. Gohlke, A. D. Kraft, C. A. McPherson, J. B. Collins, and G. Jean Harry. 2011. Voluntary exercise protects hippocampal neurons from trimethyltin injury: Possible role of interleukin-6 to modulate tumor necrosis factor receptor-mediated neurotoxicity. Brain, Behavior, and Immunity 25:1063–77. doi:10.1016/j.bbi.2011.03.012.
   PubMed Web of Science ®Google Scholar
• Gambarin–Gelwan, M., S. V. Kinkhabwala, T. D. Schiano, C. Bodian, H. Yeh, and W. Futterweit. 2007. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clinical Gastroenterology and Hepatology 5:496–501. doi:10.1016/j.cgh.2006.10.010.
   PubMed Web of Science ®Google Scholar
• Ganie, M., and S. Kalra. 2011. Polycystic ovary syndrome - A metabolic malady, the mother of all lifestyle disorders in women - Can Indian health budget tackle it in future? Indian Journal of Endocrinology and Metabolism 15:239–41. doi:10.4103/2230-8210.85571.
   PubMedGoogle Scholar
• Goodarzi, M. O., D. A. Dumesic, G. Chazenbalk, and R. Azziz. 2011. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nature Reviews Endocrinology 7:219–31. doi:10.1038/nrendo.2010.217.
   PubMed Web of Science ®Google Scholar
• Gore, A. C. 2016. Endocrine-disrupting chemicals. JAMA Internal Medicine 176:1705–06. doi:10.1001/jamainternmed.2016.5766.
   PubMed Web of Science ®Google Scholar
• Gorsky, R., E. Pamuk, D. Williamson, P. Shaffer, and J. Koplan. 1996. The 25-year health care costs of women who remain overweight after 40 years of age. American Journal of Preventive Medicine 12:388–94.
   PubMed Web of Science ®Google Scholar
• Gozukara, I. O., K. H. Gozukara, S. K. Kucur, E. U. Karakilic, H. Keskin, D. Akdeniz, A. N. Aksoy, and A. Carlioglu. 2015. Association of glomerular filtration rate with inflammation in polycystic ovary syndrome. International Journal of Fertility and Sterility 9:176–82. doi:10.22074/ijfs.2015.4238.
   PubMed Web of Science ®Google Scholar
• Graceli, J. B., G. C. Sena, P. F. I. Lopes, G. C. Zamprogno, M. B. Da Costa, A. F. L. Godoi, D. M. Dos Santos, M. R. R. De Marchi, and M. A. Dos Santos Fernandez. 2013. Organotins: A review of their reproductive toxicity, biochemistry, and environmental fate. Reproductive Toxicology 36:40–52. doi:10.1016/j.reprotox.2012.11.008.
   PubMed Web of Science ®Google Scholar
• Grote, K., B. Stahlschmidt, C. E. Talsness, C. Gericke, K. E. Appel, and I. Chahoud. 2004. Effects of organotin compounds on pubertal male rats. Toxicology 202:145–58. doi:10.1016/j.tox.2004.05.003.
   PubMed Web of Science ®Google Scholar
• Grün, F., and B. Blumberg. 2006. Environmental obesogens: Organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147:s50–s55. doi:10.1210/en.2005-1129.
   PubMed Web of Science ®Google Scholar
• Grün, F., and B. Blumberg. 2009. Endocrine disrupters as obesogens. Molecular and Cellular Endocrinology 304:19–29. doi:10.1161/CIRCRESAHA.110.234146.Molecular.
   PubMed Web of Science ®Google Scholar
• Grün, F., H. Watanabe, Z. Zamanian, L. Maeda, K. Arima, R. Cubacha, D. M. Gardiner, J. Kanno, T. Iguchi, and B. Blumberg. 2006. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Molecular Endocrinology 20:2141–55. doi:10.1210/me.2005-0367.
   PubMed Web of Science ®Google Scholar
• Guzick, D. S., E. O. Talbott, K. Sutton-Tyrrell, H. C. Herzog, L. H. Kuller, and S. K. Wolfson. 1996. Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study. American Journal of Obstetrics and Gynecology 174:1224–32. doi:10.1016/S0002-9378(96)70665-8.
   PubMed Web of Science ®Google Scholar
• Harazono, A., M. Ema, and Y. Ogawa. 1996. Pre-implantation embryonic loss induced by tributyltin chloride in rats. Toxicology Letters 89:185–90. doi:10.1016/S0378-4274(96)03805-2.
   PubMed Web of Science ®Google Scholar
• Harazono, A., M. Ema, and Y. Ogawa. 1998. Evaluation of early embryonic loss induced by tributyltin chloride in rats: Phase- and dose-dependent antifertility effects. Archives of Environmental Contamination and Toxicology 34:94–99. http://www.ncbi.nlm.nih.gov/pubmed/9419278.
   PubMed Web of Science ®Google Scholar
• He, K., J. Zhang, and Z. Chen. Effect of tributyltin on the food intake and brain neuropeptide expression in rats. Endokrynologia Polska 65: 485–490. doi.org/10.5603/EP.2014.0068.
   Google Scholar
• Heilbronn, L. K., and L. V. Campbell. 2008. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Current Pharmaceutical Design 14:1225–30. doi:10.2174/138161208784246153.
   PubMed Web of Science ®Google Scholar
• Heindel, J. J. 2003. Endocrine disruptors and the obesity epidemic. Toxicological Sciences 76:247–49. doi:10.1093/toxsci/kfg255.
   PubMed Web of Science ®Google Scholar
• Ho, K. Y., and K. M. Y. Leung. 2014. Organotin contamination in seafood and its implication for human health risk in Hong Kong. Marine Pollution Bulletin 85:634–40. doi:10.1016/j.marpolbul.2013.12.039.
   PubMed Web of Science ®Google Scholar
• Hoch, M. 2001. Organotin compounds in the environment — An overview. Applied Geochemistry 16:719–43. doi:10.1016/S0883-2927(00)00067-6.
   Web of Science ®Google Scholar
• Hoeger, K. M. 2006. Role of lifestyle modification in the management of polycystic ovary syndrome. Best Practice & Research. Clinical Endocrinology and Metabolism 20:293–310. doi:10.1016/j.beem.2006.03.008.
   PubMed Web of Science ®Google Scholar
• Holland, W. L., R. A. Miller, Z. V. Wang, K. Sun, B. M. Barth, H. H. Bui, K. E. Davis, B. T. Bikman, N. Halberg, J. M. Rutkowski, M. R. Wade, V. M. Tenorio, M. S. Kuo, J. T. Brozinick, B. B. Zhang, M. J. Bimbaum, S. A. Summers, and P. E. Scherer. 2011. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature Medicine 17:55–63. doi:10.1038/nm.2277.
   PubMed Web of Science ®Google Scholar
• Homburg, R. 2008. Polycystic ovary syndrome. Best Practice and Research: Clinical Obstetrics and Gynaecology 22:261–74. doi:10.1016/j.bpobgyn.2007.07.009.
   PubMed Web of Science ®Google Scholar
• Horiguchi, T. H., S. M. Shimizy, and M. Morita. 1994. Imposex and organotin compounds in Thais clavigera and T. bronni in Japan. Journal of the Marine Biological Association of the United Kingdom 74:651–69. doi:10.1017/S002531540004772X.
   Web of Science ®Google Scholar
• Huang, C. F., C. Y. Yang, J. R. Tsai, C. T. Wu, S. H. Liu, and K. C. Lan. 2018. Low-dose tributyltin exposure induces an oxidative stress-triggered JNK-related pancreatic β-cell apoptosis and a reversible hypoinsulinemic hyperglycemia in mice. Scientific Reports 8:5734–45. doi:10.1038/s41598-018-24076-w.
   PubMed Web of Science ®Google Scholar
• Jakubowicz, D. J., M. J. Iuorno, S. Jakubowicz, K. A. Roberts, and J. E. Nestler. 2002. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87:524–29. doi:10.1210/jcem.87.2.8207.
   PubMed Web of Science ®Google Scholar
• Janesick, A., and B. Blumberg. 2011. Minireview: PPARγ as the target of obesogens. Journal of Steroid Biochemistry and Molecular Biology 127:4–8. doi:10.1016/j.jsbmb.2011.01.005.
   PubMed Web of Science ®Google Scholar
• Janesick, A., and B. Blumberg. 2012. Obesogens, stem cells and the developmental programming of obesity. International Journal of Andrology 35:437–48. doi:10.1111/j.1365-2605.2012.01247.x.
   PubMed Web of Science ®Google Scholar
• Jiang, G. B., Q. F. Zhou, and B. He. 2000. Speciation of organotin compounds, total tin, and major trace metal elements in poisoned human organs by gas chromatography-flame photometric detector and inductively coupled plasma-mass spectrometry. Environmental Science and Technology 34:2697–702. doi:10.1021/es0008822.
   Web of Science ®Google Scholar
• Jonard, S., and D. Dewailly. 2004. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Human Reproduction Update 10:107–17. doi:10.1093/humupd/dmh010.
   PubMed Web of Science ®Google Scholar
• Jones, H., V. S. Sprung, C. J. Pugh, C. Daousi, A. Irwin, N. Aziz, V. L. Adams, E. L. Thomas, J. D. Bell, G. J. Kemp, and D. J. Cuthbertson. 2012. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism 97:3709–16. doi:10.1210/jc.2012-1382.
   PubMed Web of Science ®Google Scholar
• Jordão, R., J. Casas, G. Fabrias, B. Campos, B. Piña, M. F. Lemos, A. M. V. M. Soares, R. Tauler, and C. Barata. 2015. Obesogens beyond vertebrates. Lipid Perturbation by Tributyltin in the Crustacean Daphnia Magna. Environmental Health Perspectives 123:813–19. doi:10.1289/ehp.1409163.
   PubMed Web of Science ®Google Scholar
• Kadowaki, T. 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 116:1784–92. doi:10.1172/JCI29126.
   PubMed Web of Science ®Google Scholar
• Kandaraki, E., A. Chatzigeorgiou, S. Livadas, E. Palioura, F. Economou, M. Koutsilieris, S. Palimeri, D. Panidis, and E. Diamanti-Kandarakis. 2011. Endocrine disruptors and polycystic ovary syndrome (PCOS): Elevated serum levels of bisphenol A in women with PCOS. Journal of Clinical Endocrinology and Metabolism 96:E480–E484. doi:10.1210/jc.2010-1658.
   PubMed Web of Science ®Google Scholar
• Kannan, K., and J. Falandysz. 1997. Butyltin residues in sediment, fish, fish-eating birds, harbour porpoise and human tissues from the Polish coast of the Baltic Sea. Marine Pollution Bulletin 34:203–07. doi:10.1016/S0025-326X(96)00146-4.
   Web of Science ®Google Scholar
• Kannan, K., K. Senthilkumar, and J. P. Giesy. 1999. Occurrence of butyltin compounds in human blood. Environmental Science and Technology 33:1776–79. doi:10.1021/es990011w.
   Web of Science ®Google Scholar
• Kariyazono, Y., J. Taura, Y. Hattori, Y. Ishii, S. Narimatsu, M. Fujimura, T. Takeda, and H. Yamada. 2015. Effect of in utero exposure to endocrine disruptors on fetal steroidogenesis governed by the pituitary-gonad axis: a study in rats using different ways of administration. The Journal of Toxicological Sciences 40:909–916. doi.org/10.2131/jts.40.909.
   PubMed Web of Science ®Google Scholar
• Keithly, J. C., R. D. Cardwell, and D. G. Henderson. 1999. Tributyltin in seafood from Asia, Australia, Europe, and North America: Assessment of human health risks. Human and Ecological Risk Assessment 5:337–54. doi:10.1080/10807039991289473.
   Web of Science ®Google Scholar
• Kirchner, S., T. Kieu, C. Chow, S. Casey, and B. Blumberg. 2010. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Molecular Endocrinology 24:526–39. doi:10.1210/me.2009-0261.
   PubMed Web of Science ®Google Scholar
• Kotrikla, A. 2009. Environmental management aspects for TBT antifouling wastes from the shipyards. Journal of Environmental Management 90:S77–S85. doi:10.1016/j.jenvman.2008.07.017.
   PubMed Web of Science ®Google Scholar
• Kraakman, M. J., A. J. Murphy, K. Jandeleit-Dahm, and H. L. Kammoun. 2014. Macrophage polarization in obesity and type 2 diabetes: Weighing down our understanding of macrophage function? Frontiers in Immunology 5:470. doi:10.3389/fimmu.2014.00470.
   PubMed Web of Science ®Google Scholar
• Kravariti, M., K. K. Naka, S. N. Kalantaridou, N. Kazakos, C. S. Katsouras, A. Makrigiannakis, E. A. Paraskevaidis, G. P. Chrousos, A. Tsatsoulis, and L. K. Michalis. 2005. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 90:5088–95. doi:10.1210/jc.2005-0151.
   PubMed Web of Science ®Google Scholar
• Lagerström, M., J. Strand, and Y. Eklund. 2016. Total tin and organotin speciation in historic layers of antifouling paint on leisure boat hulls. Environmental Pollution Part B 220:1333–41. doi:10.1016/j.envpol.2016.11.001.
   PubMed Web of Science ®Google Scholar
• Lai, H., X. Jia, Q. Yu, C. Zhang, J. Qiao, Y. Guan, and J. Kang. 2014. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Biology of Reproduction 91:1–11. doi:10.1095/biolreprod.114.120063.
   Web of Science ®Google Scholar
• Lao, K. H., L. Zeng, and Q. Xu. 2015. Endothelial and smooth muscle cell transformation in atherosclerosis. Current Opinion in Lipidology 26:449–56. doi:10.1097/MOL.0000000000000219.
   PubMed Web of Science ®Google Scholar
• Leal, V. D. O., and D. Mafra. 2013. Adipokines in obesity. Clinica Chimica Acta 419:87–94. doi:10.1016/j.cca.2013.02.003.
   PubMed Web of Science ®Google Scholar
• Lee, H., S. Lim, S. Yun, A. Yoon, G. Park, and H Yang. 2012. Tributyltin increases the expression of apoptosis and adipogenesis-related genes in rat ovaries. Clinical and Experimental Reproductive Medicine 39:15–21. doi.org/10.5653/cerm.2012.39.1.15.
   PubMedGoogle Scholar
• Legro, R. S., S. A. Arslanian, D. A. Ehrmann, K. M. Hoeger, M. H. Murad, R. Pasquali, and C. K. Welt. 2013. Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 98:4565–92. doi:10.1210/jc.2013-2350.
   PubMed Web of Science ®Google Scholar
• Leonie, E., A. F. Van Houten, P. Kramer, A. McLuskey, B. Karels, A. P. N. Themmen, and J. A. Visser. 2012. Reproductive and metabolic phenotype of a mouse model of PCOS. Endocrinology 153:2861–69. doi:10.1210/en.2011-1754.
   PubMed Web of Science ®Google Scholar
• Levine, K. E., D. J. Young, S. E. Afton, J. M. Harrington, A. S. Essader, F. X. Weber, R. A. Fernando, K. Thayer, E. E. Hatch, V. G. Robinson, and S. Waidyanatha. 2015. Development, validation, and application of an ultra-performance liquid chromatography-sector field inductively coupled plasma mass spectrometry method for simultaneous determination of six organotin compounds in human serum. Talanta 140:115–21. doi:10.1016/j.talanta.2015.03.022.
   PubMed Web of Science ®Google Scholar
• Li, S.-Y., Z. Song, M.-J. Song, J.-W. Qin, M.-L. Zhao, and Z.-M. Yang. 2016. Impaired receptivity and decidualization in DHEA-induced PCOS mice. Scientific Reports 6:38134. doi:10.1038/srep38134.
   PubMed Web of Science ®Google Scholar
• Lima, D., L. F. Castro, I. Coelho, R. Lacerda, M. Gesto, J. Soares, A. André, R. Capela, T. Torres, A. P. Carvalho, and M. M. Santos. 2015. Effects of tributyltin and other retinoid receptor agonists in reproductive-related endpoints in the zebrafish (Danio rerio). Journal of Toxicology and Environmental Health A 78:747–60. doi:10.1080/15287394.2015.1028301.
   PubMed Web of Science ®Google Scholar
• Lizneva, D., L. Suturina, W. Walker, S. Brakta, L. Gavrilova-Jordan, and R. Azziz. 2016. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility 106:6–15. doi:10.1016/j.fertnstert.2016.05.003.
   PubMed Web of Science ®Google Scholar
• Lo, S., A. Alléra, P. Albers, J. Heimbrecht, E. Jantzen, D. Klingmuller, and S. Steckelbroeck. 2003. Dithioerythritol (DTE) prevents inhibitory effects of triphenyltin (TPT) on the key enzymes of the human sex steroid hormone metabolism. Journal of Steroid Biochemistry and Molecular Biology 84:569–76. doi:10.1016/S0960-0760(03)00074-8.
   PubMed Web of Science ®Google Scholar
• Loffreda, S., S. Q. Yang, H. Z. Lin, C. L. Karp, M. L. Brengman, D. J. Wang, A. S. Klein, G. B. Bulkley, C. Bao, P. W. Noble, M. D. Lane, and A. M. Diehl. 1998. Leptin regulates proinflammatory immune responses. Federation of American Societies for Experimental Biology Journal 12:57–65. http://www.ncbi.nlm.nih.gov/pubmed/9438411.
   PubMed Web of Science ®Google Scholar
• Louwers, Y. V., N. W. Rayner, B. M. Herrera, L. Stolk, C. J. Groves, T. M. Barber, A. G. Uitterlinden, S. Franks, J. S. E. Laven, and M. I. McCarthy. 2014. BMI-associated alleles do not constitute risk alleles for polycystic ovary syndrome independently of BMI: A case–Control study. PLoS ONE 9:e87335. doi:10.1371/journal.pone.0087335.
   PubMed Web of Science ®Google Scholar
• Macut, D., D. Micic, G. Cvijovic, M. Sumarac, A. Kendereski, S. Zoric, and D. Pejkovic. 2001. Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS). Journal of Pediatric Endocrinology and Metabolism 14 (Suppl 5):1353–59. http://www.ncbi.nlm.nih.gov/pubmed/11964034.
   PubMedGoogle Scholar
• Maliqueo, M., A. Benrick, and E. Stener-Victorin. 2014. Rodent models of polycystic ovary syndrome: Phenotypic presentation, pathophysiology, and the effects of different interventions. Seminars in Reproductive Medicine 32:183–93. doi:10.1055/s-0034-1371090.
   PubMed Web of Science ®Google Scholar
• Maliqueo, M., B. Echiburú, N. Crisosto, P. Amigo, P. Aranda, F. Sánchez, and T. Sir-Petermann. 2009. Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome. Fertility and Sterility 92:277–82. doi:10.1016/j.fertnstert.2008.04.022.
   PubMed Web of Science ®Google Scholar
• Mannerås, L., S. Cajander, A. Holmäng, Z. Seleskovic, T. Lystig, M. Lönn, and E. Stener-Victorin. 2007. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148:3781–91. doi:10.1210/en.2007-0168.
   PubMed Web of Science ®Google Scholar
• Mannerås-Holm, L., H. Leonhardt, J. Kullberg, E. Jennische, A. Odén, G. Holm, M. Hellström, L. Lönn, G. Olivecrona, E. Stener-Victorin, and M. Lönn. 2011. Adipose tissue has aberrant morphology and function in PCOS: Enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. Journal of Clinical Endocrinology and Metabolism 96:E304–E311. doi:10.1210/jc.2010-1290.
   PubMed Web of Science ®Google Scholar
• Mantzoros, C. S., A. Dunaif, and J. S. Flier. 1997. Leptin concentrations in the polycystic ovary syndrome 1. Journal of Clinical Endocrinology and Metabolism 82:1687–91. doi:10.1210/jcem.82.6.4017.
   PubMed Web of Science ®Google Scholar
• McCartney, C. R., and J. C. Marshall. 2016. Polycystic ovary syndrome. New England Journal of Medicine 375:54–64. doi:10.1056/NEJMcp1514916.
   PubMed Web of Science ®Google Scholar
• Meador, J. P. 2000. Predicting the fate and effects of tributyltin in marine systems. Reviews of Environmental Contamination and Toxicology 166:1–48.
   PubMed Web of Science ®Google Scholar
• Merlo, E., P. L. Podratz, G. C. Sena, J. F. P. De Araújo, L. C. F. Lima, I. S. S. Alves, L. N. Gama-de-Souza, R. Pelição, L. C. M. Rodrigues, P. A. A. Brandão, M. T. Carneiro, R. G. Pires, C. Martins-Silva, T. A. Alarcon, L. Miranda-Alves, I. V. Silva, and J. B. Graceli. 2016. The environmental pollutant tributyltin chloride disrupts the hypothalamic-pituitary-adrenal axis at different levels in female rats. Endocrinology 157:2978–95. doi:10.1210/en.2015-1896.
   PubMed Web of Science ®Google Scholar
• Mirzaei, K., A. Hossein-Nezhad, S. Keshavarz, F. Koohdani, A. A. Saboor-Yaraghi, S. Hosseini, M. R. Eshraghian, and M. Djalali. 2013. Crosstalk between circulating peroxisome proliferator-activated receptor gamma, adipokines and metabolic syndrome in obese subjects. Diabetology and Metabolic Syndrome 5:79. doi:10.1186/1758-5996-5-79.
   PubMed Web of Science ®Google Scholar
• Mitra, S., A. Srivastava, and S. Khandelwal. 2013. Tributyltin chloride induced testicular toxicity by JNK and p38 activation, redox imbalance and cell death in sertoli-germ cell co-culture. Toxicology 314:39–50. doi:10.1016/j.tox.2013.09.003.
   PubMed Web of Science ®Google Scholar
• Moran, L. J., R. J. Norman, and H. J. Teede. 2015. Metabolic risk in PCOS: Phenotype and adiposity impact. Trends in Endocrinology and Metabolism 26:136–43. doi:10.1016/j.tem.2014.12.003.
   PubMed Web of Science ®Google Scholar
• Norman, R. J., D. Dewailly, R. S. Legro, and T. E. Hickey. 2007. Polycystic ovary syndrome. Lancet 370:685–97. doi:10.1016/S0140-6736(07)61345-2.
   PubMed Web of Science ®Google Scholar
• Nielsen, J.B., and J. Strand. Butyltin compounds in human liver. Research Environmental 88: 129–133. doi.org/10.1006/enrs.2001.4321.
   Google Scholar
• Ogata, R., M. Omura, Y. Shimasaki, K. Kubo, Y. Oshima, S. Aou, and N. Inoue. 2001. Twogeneration reproductive toxicity study of tributyltin chloride in female rats. Journal of Toxicology and Environmental Health, Part A: Current Issues 63:127–144. doi.org/10.1080/15287390151126469.
   PubMed Web of Science ®Google Scholar
• Orio, F., G. Matarese, S. Di Biase, S. Palomba, D. Labella, V. Sanna, S. Savastano, F. Zullo, A. Colao, and G. Lombardi. 2003. Exon 6 and 2 peroxisome proliferator-activated receptor-γ polymorphisms in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88:5887–92. doi:10.1210/jc.2002-021816.
   PubMed Web of Science ®Google Scholar
• Orio, F., S. Palomba, T. Cascella, B. De Simone, F. Manguso, S. Sabastano, T. Russo, A. Tolino, F. Zullo, G. Lombardi, R. Azziz, and A. Colao. 2005. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study. Journal of Clinical Endocrinology and Metabolism 90:6072–76. doi:10.1210/jc.2005-0965.
   PubMed Web of Science ®Google Scholar
• Padmanabhan, V., and A. Veiga-Lopez. 2013. Animal models of the polycystic ovary syndrome phenotype. Steroids 78:734–40. doi:10.1016/j.steroids.2013.05.004.
   PubMed Web of Science ®Google Scholar
• Pan, W. W., and M. G. Myers. 2018. Leptin and the maintenance of elevated body weight. Nature Reviews Neuroscience 19:95–105. doi:10.1038/nrn.2017.168.
   PubMed Web of Science ®Google Scholar
• Paradisi, G., H. O. Steinberg, A. Hempfling, J. Cronin, G. Hook, M. K. Shepard, and A. D. Baron. 2001. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103:1410–15. doi:10.1161/01.CIR.103.10.1410.
   PubMed Web of Science ®Google Scholar
• Penza, M., M. Jeremic, E. Marrazzo, A. Maggi, P. Ciana, G. Rando, P. G. Grigolato, and D. Di Lorenzo. 2011. The environmental chemical tributyltin chloride (TBT) shows both estrogenic and adipogenic activities in mice which might depend on the exposure dose. Toxicology and Applied Pharmacology 255:65–75. doi:10.1016/j.taap.2011.05.017.
   PubMed Web of Science ®Google Scholar
• Podratz, P. L., V. S. D. Filho, P. F. I. Lopes, G. C. Sena, S. T. Matsumoto, V. Y. Samoto, C. M. Takiya, E. D. C. Miguel, I. V. Silva, and J. B. Graceli. 2012. Tributyltin impairs the reproductive cycle in female rats. Journal of Toxicology and Environmental Health A 75 (1035–1046). doi: 10.1080/15287394.2012.697826.
   PubMedGoogle Scholar
• Podratz, P. L., E. Merlo, G. C. Sena, M. Morozesk, M. M. Bonomo, S. T. Matsumoto, M. B. Da Costa, G. C. Zamprogno, P. A. A. Brandão, M. T. W. D. Carneiro, E. C. Miguel, L. Miranda-Alves, I. V. Silva, and J. B. Graceli. 2015. Accumulation of organotins in seafood leads to reproductive tract abnormalities in female rats. Reproductive Toxicology 57:29–42. doi:10.1016/j.reprotox.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Rantakokko, P., T. Kuningas, K. Saastamoine, and T. Vartiainen. 2006. Dietary intake of organotin compounds in Finland: A market-basket study. Food Additives and Contaminants 23:749–56. doi:10.1080/02652030600779908.
   PubMed Web of Science ®Google Scholar
• Rantakokko, P., K. M. Main, C. Wohlfart-Veje, H. Kiviranta, R. Airaksinen, T. Vartiainen, N. E. Skakkebaek, J. Toppari, and H. E. Virtanen. 2013. Association of placenta organotin concentrations with congenital cryptorchidism and reproductive hormone levels in 280 newborn boys from Denmark and Finland. Human Reproduction 28:1647–60. doi:10.1093/humrep/det040.
   PubMed Web of Science ®Google Scholar
• Rantakokko, P., K. M. Main, C. Wohlfart-Veje, H. Kiviranta, R. Airaksinen, T. Vartiainen, N. E. Skakkebaek, J. Toppari, and H. E. Virtanen. 2014. Association of placenta organotin concentrations with growth and ponderal index in 110 newborn boys from Finland during the first 18 months of life: A cohort study. Environmental Health 13:45. doi:10.1186/1476-069X-13-45.
   PubMed Web of Science ®Google Scholar
• Rao, J. R., D. J. Keating, C. Chen, and H. C. Parkington. 2012. Adiponectin increases insulin content and cell proliferation in MIN6 cells via PPARγ-dependent and PPARγ-independent mechanisms. Diabetes, Obesity and Metabolism 14:983–89. doi:10.1111/j.1463-1326.2012.01626.x.
   PubMed Web of Science ®Google Scholar
• Ratziu, V., S. Bellentani, H. Cortez-Pinto, C. Day, and G. Marchesini. 2010. A position statement on NAFLD/NASH based on the EASL 2009 special conference. Journal of Hepatology 53:372–84. doi:10.1016/j.jhep.2010.04.008.
   PubMed Web of Science ®Google Scholar
• Rebuffé-Scrive, M., B. Andersson, L. Olbe, and P. Björntorp. 1989. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism 38:453–58. doi:10.1016/0026-0495(89)90198-4.
   PubMed Web of Science ®Google Scholar
• Ribeiro Júnior, R. F., V. B. Marques, D. O. Nunes, K. D. S. Ronconi, J. F. P. De Araújo, P. L. Rodrigues, A. S. Padilha, D. V. Vassallo, J. B. Graceli, and I. Stefanon. 2016. Tributyltin chloride increases phenylephrine-induced contraction and vascular stiffness in mesenteric resistance arteries from female rats. Toxicology and Applied Pharmacology 295:26–36. doi:10.1016/j.taap.2016.02.005.
   PubMed Web of Science ®Google Scholar
• Ristow, M., D. Müller-Wieland, A. Pfeiffer, W. Krone, and C. R. Kahn. 1998. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. New England Journal of Medicine 339:953–59. doi:10.1056/NEJM199810013391403.
   PubMed Web of Science ®Google Scholar
• Rodrigues, S. M. L., C. F. Ximenes, P. R. De Batista, F. V. Simões, P. H. P. Coser, G. C. Sena, P. L. Podratz, L. N. G. De Souza, D. V. Vassallo, J. B. Graceli, and I. Stefanon. 2014. Tributyltin contributes in reducing the vascular reactivity to phenylephrine in isolated aortic rings from female rats. Toxicology Letters 225:378–85. doi:10.1016/j.toxlet.2014.01.002.
   PubMed Web of Science ®Google Scholar
• Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000. Transcriptional regulation of adipogenesis. Genes and Development 14:1293–307. doi:10.1101/gad.14.11.1293.
   PubMed Web of Science ®Google Scholar
• Rüdel, H. 2003. Case study: Bioavailability of tin and tin compounds. Ecotoxicology and Environmental Safety 56:180–89. doi:10.1016/S0147-6513(03)00061-7.
   PubMed Web of Science ®Google Scholar
• Ruiz, J. M., G. Bachelet, P. Caumette, and O. F. X. Donard. 1996. Three decades of tributyltin in the coastal environment with emphasis on Arcachon Bay, France. Environmental Pollution 93:195–203. doi:10.1016/0269-7491(96)00029-2.
   PubMed Web of Science ®Google Scholar
• Rutkowska, A. Z., and E. Diamanti-Kandarakis. 2016. Polycystic ovary syndrome and environmental toxins. Fertility and Sterility 106:948–58. doi:10.1016/j.fertnstert.2016.08.031.
   PubMed Web of Science ®Google Scholar
• Salley, K. E. S., E. P. Wickham, K. I. Cheang, P. A. Essah, N. W. Karjane, and J. E. Nestler. 2007. POSITION STATEMENT: Glucose intolerance in polycystic ovary syndrome—A position statement of the androgen excess society. Journal of Clinical Endocrinology and Metabolism 92:4546–56. doi:10.1210/jc.2007-1549.
   PubMed Web of Science ®Google Scholar
• Savaris, R. F., J. M. Groll, S. L. Young, F. J. DeMayo, J. W. Jeong, A. E. Hamilton, L. C. Giudice, and B. A. Lessey. 2011. Progesterone resistance in PCOS endometrium: A microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. Journal of Clinical Endocrinology and Metabolism 96:1737–46. doi:10.1210/jc.2010-2600.
   PubMed Web of Science ®Google Scholar
• Sena, G. C., L. C. Freitas-Lima, E. Merlo, P. L. Podratz, J. F. P. De Araújo, P. A. A. Brandão, M. T. W. D. Carneiro, M. C. Zicker, A. V. M. Ferreira, C. M. Takiya, C. M. De Lemos Barbosa, M. M. Morales, A. P. Santos-Silva, L. Miranda-Alves, I. V. Silva, and J. B. Graceli. 2017. Environmental obesogen tributyltin chloride leads to abnormal hypothalamic-pituitary-gonadal axis function by disruption in kisspeptin/leptin signaling in female rats. Toxicology and Applied Pharmacology 319:22–38. doi:10.1016/j.taap.2017.01.021.
   PubMed Web of Science ®Google Scholar
• Setji, T. L., N. D. Holland, L. L. Sanders, K. C. Pereira, A. M. Diehl, and A. J. Brown. 2006. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 91:1741–47. doi:10.1210/jc.2005-2774.
   PubMed Web of Science ®Google Scholar
• Shi, D., M. K. Dyck, R. R. E. Uwiera, J. C. Russell, S. D. Proctor, and D. F. Vine. 2009. A Unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome. Endocrinology 150:4425–36. doi:10.1210/en.2008-1612.
   PubMed Web of Science ®Google Scholar
• Shi, H. P. Zhu, and S. Guo. 2014. Effects of tributyltin on metamorphosis and gonadal differentiation of Xenopus laevis at environmentally relevant concentrations. Toxicology and Industrial Health 30:297–303. doi:10.1177/0748233712457440.
   PubMed Web of Science ®Google Scholar
• Si, J., X. Han, F. Zhang, Q. Xin, L. An, G. Li, and C. Li. 2012. Perinatal exposure to low doses of tributyltin chloride advances puberty and affects patterns of estrous cyclicity in female mice. Environmental Toxicology 27:662–670. doi.org/10.1002/tox.21756.
   PubMed Web of Science ®Google Scholar
• Silva, P. V., A. R. R. Silva, S. Mendo, and S. Loureiro. 2014. Toxicity of tributyltin (TBT) to terrestrial organisms and its species sensitivity distribution. Science of the Total Environment 466-467:1037–46. doi:10.1016/j.scitotenv.2013.08.002.
   PubMed Web of Science ®Google Scholar
• Solomon, R., and V. Krishnamurty. 1992. The effect of tributyltin chloride on vascular responses to atrial natriuretic peptide. Toxicology 76:39–47.
   PubMed Web of Science ®Google Scholar
• Sonak, S., P. Pangam, A. Giriyan, and K. Hawaldar. 2009. Implications of the ban on organotins for protection of global coastal and marine ecology. Journal of Environmental Management 90:96–108. doi:10.1016/j.jenvman.2008.08.017.
   PubMed Web of Science ®Google Scholar
• Sousa, A. C. A., S. D. Coelho, M. R. Pastorinho, L. Taborda-Barata, A. J. A. Nogueira, T. Isobe, T. Kunisue, S. Takahashi, and S. Tanabe. 2017. Levels of TBT and other selected organotin compounds in duplicate diet samples. Science of the Total Environment 574:19–23. doi:10.1016/j.scitotenv.2016.09.037.
   PubMed Web of Science ®Google Scholar
• Sun, H. W., S. G. Dai, and G. L. Huang. 2005. Advances in research of organotin compounds in environment. In Advances in Environmental Chemistry, 247–63. Beijing: Chemical Industry Press. (in Chinese).
   Google Scholar
• Tabb, M. M., and B. Blumberg. 2006. New modes of action for endocrine-disrupting chemicals. Molecular Endocrinology 20:475–82. doi:10.1210/me.2004-0513.
   PubMed Web of Science ®Google Scholar
• Takahashi, S., H. Mukai, S. Tanabe, K. Sakayama, T. Miyazaki, and H. Masuno. 1999. Butyltin residues in livers of humans and wild terrestrial mammals and in plastic products. Environmental Pollution 106:213–18. doi:10.1016/S0269-7491(99)00068-8.
   PubMed Web of Science ®Google Scholar
• Talbott, E., D. Guzick, A. Clerici, S. Berga, K. Detre, K. Weimer, and L. Kuller. 1995. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 15:821–26. doi:10.1161/01.ATV.15.7.821.
   PubMed Web of Science ®Google Scholar
• Talbott, E. O., D. S. Guzick, K. Sutton-Tyrrell, K. P. McHugh-Pemu, J. V. Zborowski, K. E. Remsberg, and L. H. Kuller. 2000. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arteriosclerosis, Thrombosis, and Vascular Biology 20:2414–21. http://www.ncbi.nlm.nih.gov/pubmed/11073846.
   PubMed Web of Science ®Google Scholar
• Talbott, E. O., J. V. Zborowski, J. R. Rager, M. Y. Boudreaux, D. A. Edmundowicz, and D. S. Guzick. 2004. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 89:5454–61. doi:10.1210/jc.2003-032237.
   PubMed Web of Science ®Google Scholar
• Tarkun, I., B. Cetinarslan, E. Türemen, T. Sahin, Z. Cantürk, and B. Komsuoglu. 2005. Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome. European Journal of Endocrinology 153:115–21. doi:10.1530/eje.1.01948.
   PubMed Web of Science ®Google Scholar
• Teede, H., A. Deeks, and L. Moran. 2010. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine 8:41. doi:10.1186/1741-7015-8-41.
   PubMed Web of Science ®Google Scholar
• Torchen, L. C. 2017. Cardiometabolic risk in PCOS: More than a reproductive disorder. Current Diabetes Reports 17:12. doi:10.1007/s11892-017-0956-2.
   PubMed Web of Science ®Google Scholar
• Tostes, R. C., D. Nigro, Z. B. Fortes, and M. H. Carvalho. 2003. Effects of estrogen on the vascular system. Brazilian Journal of Medical and Biological Research 36:1143–58. doi:10.1590/S0100-879X2003000900002.
   PubMed Web of Science ®Google Scholar
• Toulis, K. A., D. G. Goulis, D. Farmakiotis, N. A. Georgopoulos, I. Katsikis, B. C. Tarlatzis, I. Papadimas, and D. Panidis. 2009. Adiponectin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis. Human Reproduction Update 15:297–307. doi:10.1093/humupd/dmp006.
   PubMed Web of Science ®Google Scholar
• Tsilchorozidou, T., C. Overton, and G. S. Conway. 2004. The pathophysiology of polycystic ovary syndrome. Clinical Endocrinology 60:1–17. http://www.ncbi.nlm.nih.gov/pubmed/14678281.
   PubMed Web of Science ®Google Scholar
• Tsuda, T., D. T. Inoue, M. Kojima, and S. Aoki. 1995. Daily intakes of tributyltin and triphenyltin compounds from meals. Journal of Association of Official Analytical Chemists 78:941–43.
   Google Scholar
• United States Environmental Protection Agency. 1997. Tributyltin oxide: Toxicological review. CAS No. 56-35-9. July 1997. US EPA/ USA.
   Google Scholar
• United States Environmental Protection Agency, 2003. Ambient aquatic life water quality criteria for Tributyltin (TBT)—Final. Office of Water. EPA 822-R-03-031. December 2003. US EPA/ USA.
   Google Scholar
• Valenzuela, A., G. Lespes, W. Quiroz, L. F. Aguilar, and M. A. Bravo. 2014. Speciation analysis of organotin compounds in human urine by headspace solid-phase micro-extraction and gas chromatography with pulsed flame photometric detection. Talanta 125:196–203. doi:10.1016/j.talanta.2014.02.054.
   PubMed Web of Science ®Google Scholar
• Vidal-Puig, A. J., R. V. Considine, M. Jimenez-Liñan, A. Werman, W. J. Pories, J. F. Caro, and J. S. Flier. 1997. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. Journal of Clinical Investigation 99:2416–22. doi:10.1172/JCI119424.
   PubMed Web of Science ®Google Scholar
• Vos, J. G., A. De Klerk, E. I. Krajnc, H. Van Loveren, and J. Rozing. 1990. Immunotoxicity of Bis(tri-n-butyltin)oxide in the rat: Effects on thymus-dependent immunity and on nonspecific resistance following long-term exposure in young versus aged rats. Toxicology and Applied Pharmacology 105:144–55. doi:10.1016/0041-008X(90)90366-3.
   PubMed Web of Science ®Google Scholar
• Weil, S., K. Vendola, J. Zhou, and C. A. Bondy. 1999. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. Journal of Clinical Endocrinology and Metabolism 84:2951–56. doi:10.1210/jcem.84.8.5929.
   PubMed Web of Science ®Google Scholar
• Whalen, M. M., B. G. Loganathan, and K. Kannan. 1999. Immunotoxicity of environmentally relevant concentrations of butyltins on human natural killer cells in vitro. Environmental Research 81:108–16. doi:10.1006/enrs.1999.3968.
   PubMed Web of Science ®Google Scholar
• Wild, R. A., E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H. F. Escobar-Morreale, W. Futterweit, R. Lobo, R. J. Norman, E. Talbott, and D. A. Dumesic. 2010. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. Journal of Clinical Endocrinology and Metabolism 95:2038–49. doi:10.1210/jc.2009-2724.
   PubMed Web of Science ®Google Scholar
• Wu, S., S. Divall, A. Nwaopara, S. Radovick, F. Wondisford, C. Ko, and A. Wolfe. 2014. Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell. Diabetes 63:1270–82. doi:10.2337/db13-1514.
   PubMed Web of Science ®Google Scholar
• Wu, S., S. Divall, F. Wondisford, and A. Wolfe. 2012. Reproductive tissues maintain insulin sensitivity in diet-induced obesity. Diabetes 61:114–23. doi:10.2337/db11-0956.
   PubMed Web of Science ®Google Scholar
• Ximenes, C. F., S. M. L. Rodrigues, P. L. Podratz, E. Merlo, J. F. P. De Araújo, L. C. M. Rodrigues, J. B. Coitinho, D. V. Vassallo, J. B. Graceli, and I. Stefanon. 2017. Tributyltin chloride disrupts aortic vascular reactivity and increases reactive oxygen species production in female rats. Environmental Science and Pollution Research 24:24509–20. doi:10.1007/s11356-017-0061-8.
   PubMed Web of Science ®Google Scholar
• Yanes, L. L., D. G. Romero, M. Moulana, R. Lima, D. D. Davis, H. Zhang, R. Lockhart, L. C. Racusen, and J. F. Reckelhoff. 2011. Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gender Medicine 8:103–15. doi:10.1016/j.genm.2010.11.013.
   PubMedGoogle Scholar
• Yang, R., Q. Zhou, J. Liu, and G. Jiang. 2006. Butyltins compounds in molluscs from Chinese Bohai coastal waters. Food Chemistry 97:637–43. doi:10.1016/j.foodchem.2005.03.049.
   Web of Science ®Google Scholar
• Ye, R., and P. E. Scherer. 2013. Adiponectin, driver or passenger on the road to insulin sensitivity? Molecular Metabolism 2:133–41. doi:10.1016/j.molmet.2013.04.001.
   PubMed Web of Science ®Google Scholar
• Yoon, K., S. J. Kwack, H. S. Kim, and B. M. Lee. 2014. Journal of Toxicology and Environmental Health B 17: 127–74. doi:10.1080/10937404.2014.882194.
   PubMed Web of Science ®Google Scholar
• Yuan, X., T. Hu, H. Zhao, Y. Huang, R. Ye, J. Lin, C. Zhang, H. Zhang, G. Wei, H. Zhou, M. Dong, J. Zhao, H. Wang, Q. Liu, H. J. Lee, W. Jin, and Z. J. Chen. 2016. Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Proceedings of the National Academy of Sciences 113:2708–13. doi:10.1073/pnas.1523236113.
   PubMed Web of Science ®Google Scholar
• Zhang, J. L., Z. H. Zuo, Y. Q. Wang, A. Yu, Y. X. Chen, and C. G. Wang. 2011. Tributyltin chloride results in dorsal curvature in embryo development of Sebastiscus marmoratus via apoptosis pathway. Chemosphere 82:437–42. doi:10.1016/j.chemosphere.2010.09.057.
   PubMed Web of Science ®Google Scholar
• Zoeller, R. T., T. R. Brown, L. L. Doan, A. C. Gore, N. E. Skakkebaek, A. M. Soto, T. J. Woodruff, and F. S. Vom Saal. 2012. Endocrine-disrupting chemicals and public health protection: A statement of principles from the Endocrine Society. Endocrinology 153:4097–110. doi:10.1210/en.2012-1422.
   PubMed Web of Science ®Google Scholar
• Zuo, Z., S. Chen, T. Wu, J. Zhang, Y. Su, Y. Chen, and C. Wang. 2011. Tributyltin causes obesity and hepatic steatosis in male mice. Environmental Toxicology 26:79–85. doi:10.1002/tox.20531.
   PubMed Web of Science ®Google Scholar
• Zuo, Z., T. Wu, M. Lin, S. Zhang, F. Yan, Z. Yang, Y. Wang, and C. Wang. 2014. Chronic exposure to tributyltin chloride induces pancreatic islet cell apoptosis and disrupts glucose homeostasis in male mice. Environmental Science and Technology 48:5179–86. doi:10.1021/es404729p.
   PubMed Web of Science ®Google Scholar